| Literature DB >> 28637793 |
Brian W Wong1,2, Elke Marsch1,2, Lucas Treps1,2, Myriam Baes3, Peter Carmeliet4,2.
Abstract
In contrast to the general belief, endothelial cell (EC) metabolism has recently been identified as a driver rather than a bystander effect of angiogenesis in health and disease. Indeed, different EC subtypes present with distinct metabolic properties, which determine their function in angiogenesis upon growth factor stimulation. One of the main stimulators of angiogenesis is hypoxia, frequently observed in disease settings such as cancer and atherosclerosis. It has long been established that hypoxic signalling and metabolism changes are highly interlinked. In this review, we will provide an overview of the literature and recent findings on hypoxia-driven EC function and metabolism in health and disease. We summarize evidence on metabolic crosstalk between different hypoxic cell types with ECs and suggest new metabolic targets.Entities:
Keywords: cancer; cardiovascular disease; endothelial cell; hypoxia; metabolism
Mesh:
Year: 2017 PMID: 28637793 PMCID: PMC5538796 DOI: 10.15252/embj.201696150
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598